Article
Caspase recruiting domain-containing protein 11 (CARD11) serves as a therapeutic biomarker for the drug therapies of clear cell renal cell carcinoma
2023-12-06
Abstract excerpt
Clear cell renal cell carcinoma (ccRCC) belongs to the ten most diagnosed cancer types worldwide. Novel drug therapies are introduced and beneficial to the advanced ccRCC but lack effective biomarkers for the therapeutic response. Tumor-infiltrating immune cells and gene signatures are two critical factors for the response to immunotherapy and targeted therapy. Meanwhile, Caspase recruiting domain-containing prote...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 58d79b86-64cc-5b1f-a5d3-fee7cc7bf8fb
- DOI
- 10.21203/rs.3.rs-3686428/v1
